Collateral for a security interest recorded Sep 14, 2022 (Vickers Venture Fund VI Pte. Ltd.).
Lapsed Sep 30, 2026 on the fee record · High confidence
20-year base term ends Dec 15, 2030
Third maintenance fee unpaid; grace period ended.
Held by Biosplice Therapeutics, Inc.
Filed Jul 10, 2013 as application 13/938,692 · Granted Sep 30, 2014
Base term, 20 years from filing
Today
Lapsed Sep 30, 2026
2010
2030
Clock starts
Dec 15, 2010
Dec 15, 2010
No longer in force
Sep 30, 2026
Sep 30, 2026
Granted
Sep 30, 2014
Sep 30, 2014
Term would have run to
Dec 15, 2030
Dec 15, 2030
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Dec 15, 2030: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 15, 2010, when application 12/968,505, the earliest non-provisional in its chain, was filed (this one was filed Jul 10, 2013) | Dec 15, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Sep 30, 2026 | High confidence |
| Computed term end | The steps above, in order | Sep 30, 2026 | High confidence |
This family
| US 8,450,340 | In force Sep 2031 | Sep 2031 |
| US 8,815,897 | Lapsed on the fee record Aug 2026 | Aug 2026 |
| US 8,846,714 | this patent Sep 2026 | Sep 2026 |
| US 8,901,150 | In force Dec 2030 | Dec 2030 |
| US 9,067,939 | In force Dec 2030 | Dec 2030 |
| US 9,446,035 | In force Dec 2030 | Dec 2030 |
| US 9,855,272 | Lapsed on the fee record Jan 2026 | Jan 2026 |
| US 10,105,370 | Lapsed on the fee record Oct 2026 | Oct 2026 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 6, 2013 Reel 30946, frame 566 | Hood, John; Kc, Sunil Kumar; Wallace, David Mark | Epitherix, LLC | Assignment of Assignor's Interest |
| Aug 6, 2013 Reel 30946, frame 591 | Epitherix, LLC | Samumed, LLC | Assignment of Assignor's Interest |
| Mar 23, 2021 Reel 55693, frame 882 | Samumed, LLC | Biosplice Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 14, 2022 Reel 61433, frame 786 | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II Limited | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI (Plan) Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers-Splice Co.-Investment LLC | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Med-Pathways II Limited | Security Interest |
| Mar 12, 2026 Reel 75109, frame 434 | TMF Group New York, LLC, Not Individually But Solely as Collateral Agent | Biosplice Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
95
later US patents cite this one
That is top 5% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.